← All organizations

Shanghai YingLi Pharmaceutical Co. Ltd.

For profitWebsite ↗

Also known as: Shanghai YingLi Pharmaceutical Co. Ltd. | Yingli Pharma US, Inc | YL-Pharma

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Feb 1, 2025

Timeline

2010s

Jan 1, 2011
Shanghai YingLi Pharmaceutical Co. Ltd.— Founded

Drugs by trial phase (12 distinct, 26 trials)

Phase 4 (1 own, 0 via acquisition)

linperlisib

Phase 2 (8 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (32)

NCT06779045Lead sponsorPhase 1Feb 1, 2025
NCT06662669Lead sponsorPhase 1/Phase 2Nov 30, 2024
NCT06548347Lead sponsorPhase 2/Phase 3Sep 10, 2024
NCT06343935Lead sponsorPhase 4Apr 30, 2024
NCT06224257CollaboratorPhase 2Dec 3, 2023
NCT06094777Lead sponsorPhase 1Nov 10, 2023
NCT06096974Lead sponsorPhase 1Oct 31, 2023
NCT06078800Lead sponsorPhase 1Sep 28, 2023
NCT06026501Lead sponsorPhase 1/Phase 2Aug 31, 2023
NCT05676710CollaboratorPhase 1Feb 10, 2023
NCT05676697CollaboratorPhase 1Jan 13, 2023
NCT05457517Lead sponsorPhase 1/Phase 2Sep 24, 2022
NCT05457517Study directorPhase 1/Phase 2Sep 24, 2022
NCT05429398Lead sponsorPhase 1Jun 30, 2022
NCT05228600CollaboratorPhase 1May 17, 2022

Details

Founded: Shanghai, CN Jan 1, 2011
Last known activity: Feb 1, 2025